Pregnancy outcomes after first trimester exposure to phentermine/fenfluramine
- 15 February 2002
- journal article
- research article
- Published by Wiley in Teratology
- Vol. 65 (3) , 125-130
- https://doi.org/10.1002/tera.10023
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Postmarketing surveillance for human teratogenicity: A model approachTeratology, 2001
- Dose-effect of fenfluramine use on the severity of valvular heart disease among fen-phen patients with valvulopathyInternational Journal of Obesity, 1999
- A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve RegurgitationNew England Journal of Medicine, 1998
- The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant DrugsNew England Journal of Medicine, 1998
- Asymptomatic Mitral and Aortic Valve Disease Is Seen in Half of the Patients Taking 'Phen-Fen'Archives of internal medicine (1960), 1998
- Further Cases of Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Handbook of TeratologyPublished by Springer Nature ,1977
- Toxicologic studies of fenfluramineToxicology and Applied Pharmacology, 1971
- Congenital anomalies in the newborninfant, including minor variationsThe Journal of Pediatrics, 1964